normal subjects

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Normal Subjects, Fecal Incontinence Trial in San Diego, Augusta (Fecobionics)

Not yet recruiting
  • Normal Subjects
  • Fecal Incontinence
  • Fecobionics
  • San Diego, California
  • +1 more
Jul 18, 2022

Normal Subjects Trial in San Diego (Fecobionics)

Completed
  • Normal Subjects
  • Fecobionics
  • San Diego, California
    California Medical Innovations Institute
May 26, 2021

Normal Subjects Trial in Sacramento (PET/CT Scan)

Completed
  • Normal Subjects
  • PET/CT Scan
  • Sacramento, California
    UC Davis
May 28, 2019

Normal Subjects Trial in Lausanne (Ingestion of artificially-sweetened beverages, Ingestion of sugar-sweetened beverages,

Completed
  • Normal Subjects
  • Ingestion of artificially-sweetened beverages
  • +2 more
  • Lausanne, Switzerland
    University of Lausanne
Dec 28, 2017

Normal Subjects Trial in Lausanne (ingestion of a test meal with sweetener, ingestion of a test meal with water)

Completed
  • Normal Subjects
  • ingestion of a test meal with sweetener
  • ingestion of a test meal with water
  • Lausanne, Vaud, Switzerland
    Department of Physiology
Oct 24, 2017

Reproducibility of Ankle Brachial Index After Maximal Exercise

Completed
  • Normal Subjects
    • Angers, France
      University Hospital
    Feb 11, 2016

    Normal Subjects Trial in Recife (Mesh nebulizer, Jet nebulizer, Noninvasive ventilation-NIV)

    Completed
    • Normal Subjects
    • Mesh nebulizer
    • +2 more
    • Recife, Pernambuco, Brazil
      Hospital das Clínicas
    Jun 27, 2013

    Normal Subjects Trial in Tacoma (nano-silver gel exposed, alcohol-based hand gel)

    Unknown status
    • Normal Subjects
    • nano-silver gel exposed
    • alcohol-based hand gel
    • Tacoma, Washington
      Madigan Army Medical Center
    Apr 15, 2008

    Normal Subjects Trial in Philadelphia (Rabeprazole)

    Completed
    • Normal Subjects
    • Philadelphia, Pennsylvania
      Temple University School of Medicine
    Jan 2, 2008